- Home
- ACT vs INSP Comparison
ACT vs INSP Comparison
Compare ACT & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACT
- INSP
- Stock Information
- Founded
- ACT 1981
- INSP 2007
- Country
- ACT United States
- INSP United States
- Employees
- ACT N/A
- INSP N/A
- Industry
- ACT Specialty Insurers
- INSP Medical/Dental Instruments
- Sector
- ACT Finance
- INSP Health Care
- Exchange
- ACT Nasdaq
- INSP Nasdaq
- Market Cap
- ACT 5.2B
- INSP 5.3B
- IPO Year
- ACT 2021
- INSP 2018
- Fundamental
- Price
- ACT $34.39
- INSP $186.06
- Analyst Decision
- ACT Buy
- INSP Buy
- Analyst Count
- ACT 4
- INSP 11
- Target Price
- ACT $36.25
- INSP $232.55
- AVG Volume (30 Days)
- ACT 616.8K
- INSP 582.0K
- Earning Date
- ACT 11-06-2024
- INSP 11-04-2024
- Dividend Yield
- ACT 2.08%
- INSP N/A
- EPS Growth
- ACT 6.96
- INSP N/A
- EPS
- ACT 4.29
- INSP 1.09
- Revenue
- ACT $1,196,188,000.00
- INSP $755,594,000.00
- Revenue This Year
- ACT N/A
- INSP $29.96
- Revenue Next Year
- ACT $4.91
- INSP $19.42
- P/E Ratio
- ACT $8.00
- INSP $170.11
- Revenue Growth
- ACT 5.45
- INSP 32.52
- 52 Week Low
- ACT $26.13
- INSP $123.00
- 52 Week High
- ACT $37.42
- INSP $257.40
- Technical
- Relative Strength Index (RSI)
- ACT 49.51
- INSP 46.09
- Support Level
- ACT $33.54
- INSP $170.23
- Resistance Level
- ACT $35.09
- INSP $191.52
- Average True Range (ATR)
- ACT 0.64
- INSP 10.24
- MACD
- ACT 0.10
- INSP -0.94
- Stochastic Oscillator
- ACT 75.78
- INSP 36.03
About ACT Enact Holdings Inc.
Enact Holdings Inc is a private mortgage insurance company serving the United States housing finance market. The principal mortgage insurance customers are originators of residential mortgage loans who determine which mortgage insurer or insurers they will use for the placement of mortgage insurance written on loans they originate. The company is engaged in the business of writing and assuming residential mortgage guaranty insurance.
About INSP Inspire Medical Systems Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.